Agency Forms Undergoing Paperwork Reduction Act Review, 66267-66269 [2018-27852]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 246 / Wednesday, December 26, 2018 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
Centers for Disease Control and
Prevention
[FR Doc. 2018–27895 Filed 12–21–18; 8:45 am]
[30Day–19–18ANU]
BILLING CODE 4163–18–P
Agency Forms Undergoing Paperwork
Reduction Act Review
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
amozie on DSK3GDR082PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Chief Operating Officer, CDC,
pursuant to Public Law 92–463. The
grant applications and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)PS19–003, Using Real-time Prescription
and Insurance Claims Data to Support
the HIV Care Continuum.
Dates: March 6–7, 2019.
Time: 10:00 a.m.–5:00 p.m., (EDT).
Place: Teleconference, Centers for Disease
Control and Prevention, Room 1080, 8
Corporate Square Blvd., Atlanta, GA 30329.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Gregory
Anderson, M.S., M.P.H., Scientific Review
Officer, CDC, 1600 Clifton Road NE, Mailstop
E60, Atlanta, Georgia 30333, (404) 718–8833,
gca5@cdc.gov.
The Chief Operating Officer, Centers for
Disease Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2018–27896 Filed 12–21–18; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
20:07 Dec 21, 2018
Jkt 247001
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Communities
Organized To Prevent Arboviruses:
Assessment of Knowledge, Attitudes,
and Vector Control Practices and SeroPrevalence and Incidence of Arboviral
Infection in Ponce, Puerto Rico (COPA
Study) to the Office of Management and
Budget (OMB) for review and approval.
CDC previously published a ‘‘Proposed
Data Collection Submitted for Public
Comment and Recommendations’’
notice on July 20, 2018 to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
66267
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
Communities Organized To Prevent
Arboviruses: Assessment of Knowledge,
Attitudes, and Vector Control Practices
and Sero-Prevalence and Incidence of
Arboviral Infection in Ponce, Puerto
Rico (COPA)—Existing Collection in use
without an OMB Control Number—
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Recent years have seen the emergence
of two epidemic arthropod-borne
viruses (arboviruses) that are
transmitted by Aedes aegypti
mosquitoes. Chikungunya virus was
introduced into the Caribbean in late
2013, and caused large epidemics of
fever with severe joint pain throughout
the Caribbean and Americas in 2014.
Zika virus was first detected in the
Americas in Brazil in 2014, spread
throughout the Americas, and has since
been associated with devastating birth
defects, Guillain-Barre syndrome, and is
the first arbovirus that can also be
transmitted through sexual contact. In
addition, the four viruses that cause
dengue were introduced to the Americas
over the past several hundred years and
have since become endemic, and yellow
fever virus has recently caused large
outbreaks in Brazil and there is risk of
importation to other counties in the
Americas.
In all of these cases, the public health
response to the spread of these
arboviruses throughout the tropics,
where their mosquito vectors thrive, has
been hampered by a lack of sustainable
and effective interventions to prevent
infection with any of these arboviruses
at the community level. Additionally,
the rapid speed with which new
arboviruses spread does not often
provide the time needed to plan and
implement community-level
interventions to decrease disease
transmission. Although several
candidate vaccines for chikungunya and
Zika are currently in clinical
development, none are yet available. A
dengue vaccine has been licensed in
several countries, but initial analyses
have suggested that decades will be
needed before it results in reduction in
transmission of dengue virus.
In recent years, community based
strategies for vector control have been
E:\FR\FM\26DEN1.SGM
26DEN1
66268
Federal Register / Vol. 83, No. 246 / Wednesday, December 26, 2018 / Notices
studied and implemented in different
countries as an alternative to vertical
strategies (e.g. insecticide spraying
delivered by government agencies). A
new intervention has recently been
demonstrated to reduce the rates of
infection with common tropical
arboviruses transmitted by Ae. aegypti
mosquitos (i.e., dengue, chikungunya,
and Zika viruses). The Camino Verde
approach utilizes community
mobilization to motivate clean-up
campaigns to reduce rates of dengue
virus infections in Nicaragua and
Mexico. However, the intervention
occurred in small communities, and has
not been evaluated in an urban setting.
There is therefore a need to determine
the effectiveness of such types of
interventions in relatively large, urban
communities.
Research suggests that vector control
programs that have substantial
community participation can have
significant and lasting impacts on vector
density, and are more cost-effective than
vertically structured programs. In
addition, these types of programs have
been reported to readily integrate with
other health or development programs,
promote an enduring sense of pride in
the home and community, and make use
of politically viable vector control
strategies.
The purpose of this study is to
establish longitudinal follow-up of a
community cohort and evaluate the
impact of vector control interventions in
14 communities in southern Puerto
Rico. The study investigators have prior
experience working in these
communities; however, there is minimal
available information regarding the
prevalence or incidence of infection
with tropical arboviruses, density of Ae.
aegypti mosquitos, or community
members’ knowledge, attitudes, and
practices regarding behaviors intended
to avoid mosquitos. Such information
will be needed to inform decisionmaking regarding the location, design,
and content of interventions to be
implemented and evaluated to reduce
the burden of these pathogens.
The questionnaire section will vary
depending on age and day of birth of
each participant. A questionnaire with
general household questions will be
administered to one household
representative in each home with one or
more participants. This representative
should be 21 years or older, or an
emancipated minor. If all eligible
household members are unemancipated
minors, a household member over the
age of 50 may act as household
representative and complete this section
of the survey only. A questionnaire on
socio-demographic information will be
administered to all participants. The
assessment of knowledge, attitudes, and
practices questionnaire will be
administered to all participants seven
years and older with questions adapted
for ages: 7–11 (younger child), 12–13
(older child), 14–50 (adult). A vector
control tools questionnaire will be
administered to all participants 21 years
or older born on an odd numbered day
of the month. The questionnaire will be
administered after written consent and
verbal assent (when appropriate) from
those present in the household at the
time of the visit. The knowledge,
attitudes, and practices questionnaire
will be focused on vector control,
healthcare-seeking behavior, and
disease occurrence. We will collect
demographic information (e.g., age, sex,
duration of time residing in Puerto
Rico), travel history, and information on
recent illnesses from all participants via
household (and individual)
questionnaires. Parents or guardians
will serve as proxy respondents for
children aged <7 years. The
questionnaires will be administered
after written consent and verbal assent
(when appropriate) from those present
in the household at the time of the visit.
GPS coordinates will also be collected
for each household visited to later
assess for potential clustering of
arboviral infections within
communities. We will ask participants if
they have been ill with arbovirus-like
illness (i.e., fever, rash, joint pain, and
conjunctivitis) in the past year. If so, we
will collect details on the symptoms
experienced during their illness. The
questionnaires will be administered to
all randomly selected residents of the 14
communities in Ponce. At the time of
the questionnaire administration, ∼15
mL of blood will be collected to conduct
serological testing of arboviruses for a
sero-survey. The sero-survey and sociodemographic questionnaire will be
repeated every 12 months after the
initial assessment, up to a period of five
years. OMB clearance will be extended
after three years. This project will allow
the evaluation of a community based
approach for vector control strategies in
Ponce, Puerto Rico. The information
obtained will inform decision making
regarding the location, design, and
content of future interventions to be
implemented and evaluated to reduce
the burden of arboviral disease in Puerto
Rico. Incidence and prevalence of
arboviral disease will be estimated to
guide control programs development
and fill the current knowledge gaps.
There is no burden on respondents
other than the time needed to
participate. Estimated annual burden is
2,416 hours. Authorizing legislation
comes from Section 301 of the Public
Health Service Act.
amozie on DSK3GDR082PROD with NOTICES1
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
Ponce residents ............................
Household representative questionnaire .........................
Socio-demographic questionnaire ....................................
Knowledge, attitudes, and practices individual questionnaire.
Vector control tools questionnaire ...................................
Specimen collection .........................................................
VerDate Sep<11>2014
20:07 Dec 21, 2018
Jkt 247001
PO 00000
Frm 00032
Fmt 4703
Sfmt 9990
E:\FR\FM\26DEN1.SGM
Number of
responses per
respondent
Average
burden per
response
(in hours)
2,506
2,996
2,996
1
1
1
10/60
15/60
15/60
600
2,996
1
1
25/60
5/60
26DEN1
Federal Register / Vol. 83, No. 246 / Wednesday, December 26, 2018 / Notices
Jeffrey M. Zirger,
Acting Lead, Information Collection Review
Office, Office of Scientific Integrity, Office
of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2018–27852 Filed 12–21–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–19–0612; Docket No. CDC–2018–
0111]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
on the Well-Integrated Screening and
Evaluation for Women Across the
Nation (WISEWOMAN) program. The
WISEWOMAN program is designed to
prevent, detect, and control,
hypertension and other cardiovascular
disease risk factors through healthy
behavior support services, which are
tailored for individual and group
behavior change.
DATES: CDC must receive written
comments on or before February 25,
2019.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2018–
0111 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
amozie on DSK3GDR082PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
20:07 Dec 21, 2018
Jkt 247001
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
reinstatement of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Well-Integrated Screening and
Evaluation for Women Across the
Nation (WISEWOMAN) (OMB No.
0920–0612, Exp. 12/31/2018)—
Reinstatement—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
66269
Background and Brief Description
The WISEWOMAN program
sponsored by the CDC, provides services
to low income, uninsured, or
underinsured women aged 40–64. The
WISEWOMAN program is designed to
prevent, detect, and control
hypertension and other CVD risk factors
through healthy behavior support
services which are tailored for
individual and group behavior change.
The WISEWOMAN program provides
services to women who are jointly
enrolled in the National Breast and
Cervical Cancer Early Detection Program
(NBCCEDP), which is also administered
by CDC.
The WISEWOMAN program is
administered by state health
departments and tribal programs. In
2018, new five-year cooperative
agreements will be awarded under
Funding Opportunity Announcement
DP18–1816, subject to the availability of
funds. CDC collects two types of
information from WISEWOMAN
awardees. The WISEWOMAN awardee
submits an electronic data file to CDC
twice per year. The Minimum Data
Elements (MDE) file contains data using
a unique identifier with client-level
information about cardiovascular
disease risk factors, types of healthy
behavior support services for
participants served by the program. The
estimated burden per response for the
MDE file is 24 hours. The Annual
Progress Report provides a narrative
summary of each awardee’s objectives
and the activities undertaken to meet
program goals. The estimated burden
per response is 16 hours.
There are no changes to the
information collected. CDC will
continue to use the information
collected from WISEWOMAN awardees
to support program monitoring and
improvement activities, evaluation, and
assessment of program outcomes. The
overall program evaluation helps to
demonstrate program accomplishments
and strengthen the evidence for strategy
implementation for improved
engagement of underserved populations.
It can also determine whether the
identified strategies and associated
activities can be implemented at various
levels within a state or tribal
organization. Evaluation is also
designed to demonstrate how
WISEWOMAN can obtain
cardiovascular disease health outcome
data on at-risk populations, promote
public education about cardiovascular
disease risk-factors, and improve the
availability of healthy behavior support
services for under-served women.
E:\FR\FM\26DEN1.SGM
26DEN1
]]>Agencies
[Federal Register Volume 83, Number 246 (Wednesday, December 26, 2018)]
[Notices]
[Pages 66267-66269]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-27852]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-19-18ANU]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Communities Organized To Prevent Arboviruses:
Assessment of Knowledge, Attitudes, and Vector Control Practices and
Sero-Prevalence and Incidence of Arboviral Infection in Ponce, Puerto
Rico (COPA Study) to the Office of Management and Budget (OMB) for
review and approval. CDC previously published a ``Proposed Data
Collection Submitted for Public Comment and Recommendations'' notice on
July 20, 2018 to obtain comments from the public and affected agencies.
CDC did not receive comments related to the previous notice. This
notice serves to allow an additional 30 days for public and affected
agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
Communities Organized To Prevent Arboviruses: Assessment of
Knowledge, Attitudes, and Vector Control Practices and Sero-Prevalence
and Incidence of Arboviral Infection in Ponce, Puerto Rico (COPA)--
Existing Collection in use without an OMB Control Number--National
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention (CDC).
Background and Brief Description
Recent years have seen the emergence of two epidemic arthropod-
borne viruses (arboviruses) that are transmitted by Aedes aegypti
mosquitoes. Chikungunya virus was introduced into the Caribbean in late
2013, and caused large epidemics of fever with severe joint pain
throughout the Caribbean and Americas in 2014. Zika virus was first
detected in the Americas in Brazil in 2014, spread throughout the
Americas, and has since been associated with devastating birth defects,
Guillain-Barre syndrome, and is the first arbovirus that can also be
transmitted through sexual contact. In addition, the four viruses that
cause dengue were introduced to the Americas over the past several
hundred years and have since become endemic, and yellow fever virus has
recently caused large outbreaks in Brazil and there is risk of
importation to other counties in the Americas.
In all of these cases, the public health response to the spread of
these arboviruses throughout the tropics, where their mosquito vectors
thrive, has been hampered by a lack of sustainable and effective
interventions to prevent infection with any of these arboviruses at the
community level. Additionally, the rapid speed with which new
arboviruses spread does not often provide the time needed to plan and
implement community-level interventions to decrease disease
transmission. Although several candidate vaccines for chikungunya and
Zika are currently in clinical development, none are yet available. A
dengue vaccine has been licensed in several countries, but initial
analyses have suggested that decades will be needed before it results
in reduction in transmission of dengue virus.
In recent years, community based strategies for vector control have
been
[[Page 66268]]
studied and implemented in different countries as an alternative to
vertical strategies (e.g. insecticide spraying delivered by government
agencies). A new intervention has recently been demonstrated to reduce
the rates of infection with common tropical arboviruses transmitted by
Ae. aegypti mosquitos (i.e., dengue, chikungunya, and Zika viruses).
The Camino Verde approach utilizes community mobilization to motivate
clean-up campaigns to reduce rates of dengue virus infections in
Nicaragua and Mexico. However, the intervention occurred in small
communities, and has not been evaluated in an urban setting. There is
therefore a need to determine the effectiveness of such types of
interventions in relatively large, urban communities.
Research suggests that vector control programs that have
substantial community participation can have significant and lasting
impacts on vector density, and are more cost-effective than vertically
structured programs. In addition, these types of programs have been
reported to readily integrate with other health or development
programs, promote an enduring sense of pride in the home and community,
and make use of politically viable vector control strategies.
The purpose of this study is to establish longitudinal follow-up of
a community cohort and evaluate the impact of vector control
interventions in 14 communities in southern Puerto Rico. The study
investigators have prior experience working in these communities;
however, there is minimal available information regarding the
prevalence or incidence of infection with tropical arboviruses, density
of Ae. aegypti mosquitos, or community members' knowledge, attitudes,
and practices regarding behaviors intended to avoid mosquitos. Such
information will be needed to inform decision-making regarding the
location, design, and content of interventions to be implemented and
evaluated to reduce the burden of these pathogens.
The questionnaire section will vary depending on age and day of
birth of each participant. A questionnaire with general household
questions will be administered to one household representative in each
home with one or more participants. This representative should be 21
years or older, or an emancipated minor. If all eligible household
members are unemancipated minors, a household member over the age of 50
may act as household representative and complete this section of the
survey only. A questionnaire on socio-demographic information will be
administered to all participants. The assessment of knowledge,
attitudes, and practices questionnaire will be administered to all
participants seven years and older with questions adapted for ages: 7-
11 (younger child), 12-13 (older child), 14-50 (adult). A vector
control tools questionnaire will be administered to all participants 21
years or older born on an odd numbered day of the month. The
questionnaire will be administered after written consent and verbal
assent (when appropriate) from those present in the household at the
time of the visit. The knowledge, attitudes, and practices
questionnaire will be focused on vector control, healthcare-seeking
behavior, and disease occurrence. We will collect demographic
information (e.g., age, sex, duration of time residing in Puerto Rico),
travel history, and information on recent illnesses from all
participants via household (and individual) questionnaires. Parents or
guardians will serve as proxy respondents for children aged <7 years.
The questionnaires will be administered after written consent and
verbal assent (when appropriate) from those present in the household at
the time of the visit. GPS coordinates will also be collected for each
household visited to later assess for potential clustering of arboviral
infections within communities. We will ask participants if they have
been ill with arbovirus-like illness (i.e., fever, rash, joint pain,
and conjunctivitis) in the past year. If so, we will collect details on
the symptoms experienced during their illness. The questionnaires will
be administered to all randomly selected residents of the 14
communities in Ponce. At the time of the questionnaire administration,
~15 mL of blood will be collected to conduct serological testing of
arboviruses for a sero-survey. The sero-survey and socio-demographic
questionnaire will be repeated every 12 months after the initial
assessment, up to a period of five years. OMB clearance will be
extended after three years. This project will allow the evaluation of a
community based approach for vector control strategies in Ponce, Puerto
Rico. The information obtained will inform decision making regarding
the location, design, and content of future interventions to be
implemented and evaluated to reduce the burden of arboviral disease in
Puerto Rico. Incidence and prevalence of arboviral disease will be
estimated to guide control programs development and fill the current
knowledge gaps.
There is no burden on respondents other than the time needed to
participate. Estimated annual burden is 2,416 hours. Authorizing
legislation comes from Section 301 of the Public Health Service Act.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Ponce residents.................... Household representative 2,506 1 10/60
questionnaire.
Socio-demographic 2,996 1 15/60
questionnaire.
Knowledge, attitudes, and 2,996 1 15/60
practices individual
questionnaire.
Vector control tools 600 1 25/60
questionnaire.
Specimen collection........ 2,996 1 5/60
----------------------------------------------------------------------------------------------------------------
[[Page 66269]]
Jeffrey M. Zirger,
Acting Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2018-27852 Filed 12-21-18; 8:45 am]
BILLING CODE 4163-18-P
